ribavirin has been researched along with Congenital Thrombotic Thrombocytopenic Purpura in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bes, M; Buti, M; Esteban, R; Gregori, J; Llorens, M; Piriz, S; Piron, M; Quer, J; Riveiro-Barciela, M; Salcedo, MT; Sauleda, S; Valcarcel, D | 1 |
| Bonnet, F; Hessamfar, M; Michaux, C; Morlat, P; Randrianasolo, D; Vandenhende, MA | 1 |
| Hanson, B; Lambot, F; Sztern, B | 1 |
| Aghemo, A; Colombo, M; Degasperi, E; Ferrari, B; Lotta, LA; Peyvandi, F | 1 |
| Grifols, JR; Ribera, JM; Serrano, A; Xicoy, B | 1 |
| Terada, H | 1 |
1 review(s) available for ribavirin and Congenital Thrombotic Thrombocytopenic Purpura
| Article | Year |
|---|---|
[Drug-induced hemolytic anemia].
Topics: Anemia, Hemolytic; Anti-Bacterial Agents; Antigen-Antibody Complex; Antiviral Agents; Autoantibodies; Diagnosis, Differential; Glucosephosphate Dehydrogenase Deficiency; Haptens; Hemolytic-Uremic Syndrome; Humans; Methyldopa; Penicillins; Procainamide; Proton Pump Inhibitors; Purpura, Thrombotic Thrombocytopenic; Quinidine; Ribavirin | 2007 |
5 other study(ies) available for ribavirin and Congenital Thrombotic Thrombocytopenic Purpura
| Article | Year |
|---|---|
Thrombotic thrombocytopenic purpura relapse induced by acute hepatitis E transmitted by cryosupernatant plasma and successfully controlled with ribavirin.
Topics: Antiviral Agents; Hepatitis E; Humans; Male; Methylene Blue; Middle Aged; Phylogeny; Plasma; Purpura, Thrombotic Thrombocytopenic; Ribavirin | 2018 |
[Thrombotic thrombocytopenic purpura associated with interferon therapy in a HIV and HCV co-infected woman].
Topics: Adult; Antiviral Agents; Coinfection; Female; Hepatitis C; HIV Infections; HIV-1; Humans; Interferon-alpha; Polyethylene Glycols; Purpura, Thrombotic Thrombocytopenic; Recombinant Proteins; Ribavirin | 2013 |
[Thrombotic thrombocytopenic purpura mediated by an ADAMTS13-inhibitor related to a treatment with pegylated-interferon alpha-2a and ribavirine in a patient with chronic hepatitis C].
Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Antiviral Agents; Autoantibodies; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Purpura, Thrombotic Thrombocytopenic; Recombinant Proteins; Ribavirin | 2010 |
Treatment of chronic hepatitis C with pegylated interferon-α in a patient with recurrent autoimmune thrombotic thrombocytopenic purpura.
Topics: ADAM Proteins; ADAMTS13 Protein; Antiviral Agents; Autoantibodies; Autoimmune Diseases; Biopsy; Female; Hepatitis C, Chronic; Hepatomegaly; Humans; Interferon-alpha; Middle Aged; Polyethylene Glycols; Purpura, Thrombotic Thrombocytopenic; Recombinant Proteins; Recurrence; Ribavirin; Splenomegaly; von Willebrand Factor | 2013 |
[Thrombotic thrombocytopenic purpura during treatment with interpheron].
Topics: Adult; Antiviral Agents; Hepatitis C; Humans; Interferon-alpha; Interferon-beta; Male; Middle Aged; Multiple Sclerosis; Purpura, Thrombotic Thrombocytopenic; Ribavirin; Time Factors | 2007 |